NEWTOWN

INVESTOR ALERT: Edelson Lechtzin LLP Urges ImmunityBio, Inc. (NASDAQ: IBRX) Shareholders with Substantial Losses to Consider Seeking Leadership in the Securities Fraud Class Action

Retrieved on: 
Wednesday, July 12, 2023
Vaccine, GMP, LLP, CMOS, Infection, HERE, Immunotherapy, District court, Immune system, Cancer, FDA, BLA, Douglas v. U.S. District Court ex rel Talk America, News, Pharmaceutical industry, ImmunityBio COVID-19 vaccine

Current holders of ImmunityBio stock may pursue corporate governance reforms.

Key Points: 
  • Current holders of ImmunityBio stock may pursue corporate governance reforms.
  • Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .
  • A copy of the class action complaint can be viewed HERE .
  • To bring these product candidates to market, ImmunityBio works with third-party contract manufacturing organizations (CMOs), including those responsible for the creation of Anktiva.

INVESTOR ALERT: Edelson Lechtzin LLP Reminds Arrow Financial Corporation (NASDAQ: AROW) Shareholders with Substantial Losses to Consider Seeking Leadership in the Securities Fraud Class Action

Retrieved on: 
Wednesday, July 12, 2023
LLP, Employment, Disclosure, Lung compliance, Form 10-K, HERE, Risk, Court, Annual report, News, Cryptocurrency, Arrow

Investors who purchased Arrow common stock may move the Court to appoint them as lead plaintiff, no later than August 22, 2023.

Key Points: 
  • Investors who purchased Arrow common stock may move the Court to appoint them as lead plaintiff, no later than August 22, 2023.
  • Current holders of Arrow stock may pursue corporate governance reforms.
  • Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .
  • On this news, Arrow’s stock price fell $0.53 per share, or 2.71%, to close at $19.06 per share on May 15, 2023.

Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Perella Weinberg Partners (NASDAQ: PWP) Shareholders Who Held FinTech Acquisition Corp. IV (NASDAQ: FTIV) Shares Prior to the Merger

Retrieved on: 
Thursday, June 29, 2023
PWP, LLP, Perella Weinberg Partners, Fintech, Fraud, Acquisition, HERE, Bank

NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of FinTech Acquisition Corp. IV (“FinTech IV”) (NASDAQ: FTIV), a special purpose acquisition company (“SPAC”), who acquired FinTech IV shares before the closing of its business combination with Perella Weinberg Partners (“PWP”) (NASDAQ: PWP), on or before June 24, 2021.

Key Points: 
  • NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of FinTech Acquisition Corp. IV (“FinTech IV”) (NASDAQ: FTIV), a special purpose acquisition company (“SPAC”), who acquired FinTech IV shares before the closing of its business combination with Perella Weinberg Partners (“PWP”) (NASDAQ: PWP), on or before June 24, 2021.
  • Perella Weinberg Partners is an independent advisory and asset management firm that provides expert strategic and financial guidance to a diverse range of clients around the globe.
  • The combined company now operates as Perella Weinberg Partners and PWP’s Class A common shares and warrants began trading on NASDAQ under the ticker symbol “PWP” on June 25, 2021.
  • FinTech IV investors who acquired PWP shares may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the merger between FinTech IV and PWP.

Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Senti Biosciences, Incorporated (NASDAQ: SNTI) Shareholders Who Held Dynamics Special Purpose Corp. (NASDAQ: DYNS) Shares Prior to the Merger

Retrieved on: 
Thursday, June 29, 2023
SNTI, Biotechnology, LLP, Fraud, Acquisition, DYNS, HERE

Senti Bio is a biotechnology company that is developing advanced cell and gene therapies.

Key Points: 
  • Senti Bio is a biotechnology company that is developing advanced cell and gene therapies.
  • Senti Bio common stock began trading on the Nasdaq Global Market under the ticker symbol “SNTI” at the opening of trading on June 9, 2022.
  • DYNS investors who acquired Senti Bio shares may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the merger between DYNS and Senti Bio.
  • Please contact Edelson Lechtzin LLP at 1-844-696-7492 to discuss your investment losses, or by e-mail at [email protected] or [email protected] , or you can submit your information online HERE .

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By Genworth Financial Data Breach

Retrieved on: 
Thursday, June 29, 2023
Insurance, Policy, LLP, GNW, ID, Address, Genworth Financial, HERE, NYSE, GF, Privacy, Private investigator

NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Genworth Financial (“GF”) (NYSE:GNW).

Key Points: 
  • NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Genworth Financial (“GF”) (NYSE:GNW).
  • GF learned of suspicious activity on or about May 30, 2023, but waited until June 22, 2023 to notify its customers of the breach.
  • GF notified its customers of the breach by a post on its website on June 22, 2023.
  • Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the GF data breach.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By CalPERS Data Breach

Retrieved on: 
Thursday, June 29, 2023
Transfer, CalPERS, LLP, HERE, Privacy, Child, Private investigator

NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by CalPERS.

Key Points: 
  • NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by CalPERS.
  • CalPERS learned of suspicious activity on or about June 6, 2023.
  • On or about June 6, 2023, PBI Research Services/Berwyn Group (“PBI”), a third-party vendor, notified CalPERS that their MOVEit Transfer Application had been hacked thereby exposing CalPERS customers’ sensitive personal data.
  • Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the CalPERS data breach.

INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Electric Last Mile Solutions, Inc. (OTC: ELMSQ) Shareholders

Retrieved on: 
Sunday, June 25, 2023
Failure, Bank statement, PIPE, HERE, ELMS, Net, BDO, District court, Acquisition, OTC, Douglas v. U.S. District Court ex rel Talk America, News, Bankruptcy, Cryptocurrency, Electricity

Investors who purchased Electric Last Mile Solutions, Inc. common stock may move the U.S. District Court for the District of Delaware to appoint them as lead plaintiff, no later than August 14, 2023.

Key Points: 
  • Investors who purchased Electric Last Mile Solutions, Inc. common stock may move the U.S. District Court for the District of Delaware to appoint them as lead plaintiff, no later than August 14, 2023.
  • Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .
  • Their first product, the Urban Delivery, was expected to be the first Class 1 commercial electric vehicle available in the United States.
  • This has caused them to be non-compliant with NASDAQ listing rules, resulting in the delisting of their stock, which is now essentially worthless, damaging investors.

Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger

Retrieved on: 
Sunday, June 25, 2023
LLP, Cancer, Fraud, Therapy, Acquisition, Medicine, Pharmaceutical industry

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Key Points: 
  • Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
  • Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts.
  • The business combination of BCTG and Tango Therapeutics was approved by shareholders of BCTG on August 9, 2021.
  • Tango Therapeutics common stock began trading on the NASDAQ under its new ticker symbol, “TNGX,” on or about August 10, 2021.

Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Skillsoft Corp. (NYSE: SKIL) Shareholders Who Held Churchill Capital Corp II (NYSE: CCX.U) Shares Prior to the Merger

Retrieved on: 
Sunday, June 25, 2023
LLP, Leadership development, Skillsoft, SKIL, Organization, Acquisition, Digital transformation, Fraud, NYSE, Private investigator

NEWTOWN, Pa., June 25, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of Churchill Capital Corp II (“Churchill II”) (NYSE: CCX.U), a special purpose acquisition company (“SPAC”), who acquired Churchill II shares before the closing of its business combination with Skillsoft Corp. (“Skillsoft”) (NYSE: SKIL ), on or before June 11, 2021.

Key Points: 
  • NEWTOWN, Pa., June 25, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of Churchill Capital Corp II (“Churchill II”) (NYSE: CCX.U), a special purpose acquisition company (“SPAC”), who acquired Churchill II shares before the closing of its business combination with Skillsoft Corp. (“Skillsoft”) (NYSE: SKIL ), on or before June 11, 2021.
  • Skillsoft provides digital learning, training, and talent solutions to assist organizations in democratizing learning.
  • They offer a customized, learner-centric approach to skills development with resources for Leadership Development, Business Skills, Technology and Developer, Digital Transformation, and Compliance.
  • Churchill II investors may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the business combination between Churchill II and Skillsoft.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By Johns Hopkins University and Health System Data Breach

Retrieved on: 
Thursday, June 22, 2023
LLP, JHU, Name, Social, Patient, Social Security, HERE, Privacy, Private investigator, D.C

NEWTOWN, Pa., June 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Johns Hopkins University and Health System (“JHU”).

Key Points: 
  • NEWTOWN, Pa., June 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Johns Hopkins University and Health System (“JHU”).
  • JHU learned of suspicious activity on or about May 31, 2023, and notified customers on or about June 14, 2023.
  • How can I protect my personal data?
  • Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the JHU data breach.